Updates to the HTA review research and analysis papers collection: emerging health technologies

15 February 2024 - The draft paper 'Emerging Health Technologies' developed to support the deliberations of the HTA Review Reference ...

Read more →

Updates to the HTA Review: consultation 2 survey

6 February 2024 - Access to the HTA Review Consultation 2 online survey is now available on the Office of ...

Read more →

Cheaper medicines for advanced melanoma and multiple sclerosis

5 February 2024 - From 1 February 2024, Australians with advanced melanoma and relapsing-remitting multiple sclerosis will have access to ...

Read more →

Schedule of Pharmaceutical Benefits - 1 February 2024

1 February 2024 - The February 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

2024 PBS post-market review framework

31 January 2024 - The 2024 post-market review framework is now available. ...

Read more →

Updates to the HTA Review: options paper for Consultation 2 published

25 January 2024 - The Options paper for Consultation 2 is now available on the Office of Health Technology Assessment consultation ...

Read more →

Outcomes from the December 2023 PBAC intracycle meeting

25 January 2024 - The outcomes from the December 2023 PBAC intracycle meeting are now available. ...

Read more →

Australians save $250 million thanks to Albanese Government cheaper medicines

22 January 2024 - Australians have saved $250 million on cheaper medicines in 2023 thanks to the Albanese Government. ...

Read more →

Advanced melanoma treatment to be added to Pharmaceutical Benefits Scheme

21 January 2024 - Treatment for advanced melanoma is set to become cheaper under the Pharmaceutical Benefits Scheme in the ...

Read more →

Updates to the HTA Policy and Methods Review Reference Committee (18 January 2024)

18 January 2024 - Communiques for three HTA Review Reference Committee meetings held in December 2023 are now available. ...

Read more →

PBAC - 2023 in review

18 January 2024 - In contrast to New Zealand, 2023 saw many new medicines listed on the PBS. ...

Read more →

DoH publishes revised agenda for March 2024 PBAC meeting (version 3)

5 January 2024 - The Department of Health has published a revised agenda (version 3) for the March 2024 PBAC ...

Read more →

Public summary documents (first time decisions not to recommend and deferrals) – September 2023 PBAC meeting

12 January 2024 - The public summary documents (first time decisions not to recommend and deferrals) from the September 2023 PBAC ...

Read more →

Updates to the HTA review research and analysis papers collection: draft HTA expert papers published

4 January 2024 - Two draft papers developed to support the deliberations of the HTA Review Reference Committee have been ...

Read more →

Expanded PBS listings make vital treatments more affordable

2 January 2024 - From 1 January 2024, Australians with advanced ovarian cancer, CLL, SLL, cystic fibrosis and atypical haemolytic uraemic ...

Read more →